Cargando…

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation

INTRODUCTION: Decreased immunosuppression has been proposed for kidney transplant recipients infected with coronavirus disease 2019 (COVID-19), but the impact on the alloreactive immune response during and after infection has been poorly investigated. We evaluated the occurrence of antihuman leukocy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masset, Christophe, Gautier-Vargas, Gabriela, Cantarovich, Diego, Ville, Simon, Dantal, Jacques, Delbos, Florent, Walencik, Alexandre, Kerleau, Clarisse, Hourmant, Maryvonne, Garandeau, Claire, Meurette, Aurélie, Giral, Magali, Benotmane, Ilies, Caillard, Sophie, Blancho, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818557/ https://www.ncbi.nlm.nih.gov/pubmed/35155848 http://dx.doi.org/10.1016/j.ekir.2022.01.1072

Ejemplares similares

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients
por: Masset, Christophe, et al.
Publicado: (2023)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
por: Masset, Christophe, et al.
Publicado: (2021)

Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation
por: Masset, Christophe, et al.
Publicado: (2022)

Early and late ANCA vasculitis relapses after kidney transplantation may have different presentations
por: Masset, Christophe, et al.
Publicado: (2022)

COVID-19 Severity in Kidney Transplant Recipients According to Their Postvaccination Serological Assessment
por: Masset, Christophe, et al.
Publicado: (2022)

Incidence, Risk Factors and Outcomes of Kidney and Liver Cyst Infection in Kidney Transplant Recipient With ADPKD
por: Ronsin, Charles, et al.
Publicado: (2022)

Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients
por: Masset, Christophe, et al.
Publicado: (2022)

Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes
por: Pacaud, Margaux, et al.
Publicado: (2022)

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8+ T cells – Analyses of a cohort of 1032 kidney transplant recipients
por: Mai, Hoa Le, et al.
Publicado: (2022)

Kidney allograft rejection is associated with an imbalance of B cells, regulatory T cells and differentiated CD28-CD8+ T cells: analysis of a cohort of 1095 graft biopsies
por: Mai, Hoa Le, et al.
Publicado: (2023)

CXCR5(+)PD1(+)ICOS(+) Circulating T Follicular Helpers Are Associated With de novo Donor-Specific Antibodies After Renal Transplantation
por: Danger, Richard, et al.
Publicado: (2019)

COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021)

Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
por: Benotmane, Ilies, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)

Sterile Pancreas Inflammation during Preservation and after Transplantation
por: Kervella, Delphine, et al.
Publicado: (2023)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection
por: Colas, Luc, et al.
Publicado: (2021)

Comparison of the risk factors effects between two populations: two alternative approaches illustrated by the analysis of first and second kidney transplant recipients
por: Trébern-Launay, Katy, et al.
Publicado: (2013)

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)

Urinary metabolomic profiling from spontaneous tolerant kidney transplanted recipients shows enrichment in tryptophan-derived metabolites
por: Colas, Luc, et al.
Publicado: (2022)

HLA‐EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities
por: Geffard, Estelle, et al.
Publicado: (2021)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021)

L’immunosuppression et le défaut d’immunogénicité des vaccins à ARNm limitent la protection des patients transplantés vaccinés selon le schéma standard : plaidoyer pour une 3(e) dose
por: Charmetant, X., et al.
Publicado: (2021)

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
por: Benotmane, Ilies, et al.
Publicado: (2022)

Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort
por: Boucquemont, Julie, et al.
Publicado: (2020)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

La SFNDT dans la crise de l’épidémie COVID-19
por: Hourmant, Maryvonne, et al.
Publicado: (2021)

Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C(+)CD57(+)NK and δ2(-)γδT cell subsets
por: Rousselière, Amélie, et al.
Publicado: (2022)

Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2022)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study
por: Gaisne, Raphaël, et al.
Publicado: (2020)

Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia
por: Solis, Morgane, et al.
Publicado: (2022)

Renal transplantation outcomes in obese patients: a French cohort-based study
por: Foucher, Y., et al.
Publicado: (2021)

Complications neurologiques du COVID-19 chez les patients atteints de maladie rénale
por: Perrin, P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96ga0jtojcr0i595ebqed9j1nj